Home » Archive by Category


San Diego biotech news from BioSpace, Xconomy, PR Newswire, Marketwired and other sources, click on headlines to read the full story.

CytRx Corporation Launches Discovery Laboratory To Develop Albumin-Binding Anti-Cancer Drug Platform

October 13, 2014 – 5:00 am | Edit Post

LOS ANGELES, Oct. 13, 2014 /PRNewswire/ –CytRx Corporation (NASDAQ: CYTR), a biopharmaceutical research and development company specializing in oncology, today announced that it has commenced operations at its new discovery laboratory, located in Freiburg, Germany. The new laboratory will conduct discovery…

Analysts: Harvoni News Nothing But Upside For Gilead Sciences, Inc.

October 13, 2014 – 5:00 am | Edit Post

Biocept, Inc. And Rosetta Genomics Ltd. Collaborate To Evaluate Micrornas From Circulating Tumor Cells

October 13, 2014 – 5:00 am | Edit Post

SAN DIEGO and PRINCETON, N.J. and REHOVOT, Israel, Oct. 13, 2014 (GLOBE NEWSWIRE) — Biocept, Inc. (Nasdaq:BIOC), a molecular oncology diagnostics company specializing in biomarker analysis of cell-free circulating tumor DNA (cfDNA) and circulating tumor cells (CTCs), and Rosetta Genomics, Ltd. (Nasdaq…

Kite Pharma, Inc. Announces Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia (ALL) Experience Positive Results After Receiving Anti-CD19 Chimeric Antigen Receptor (CAR) T Cells

October 13, 2014 – 5:00 am | Edit Post

Phase 1 Clinical Trial Highlights: 14 of 20 pediatric or young adult patients (70%) with relapsed or refractory ALL experienced a complete response. 12 of the 20 patients (60%) achieved a minimal…

Kythera Biopharmaceuticals Grants Stock Options Under Inducement Program

October 13, 2014 – 5:00 am | Edit Post

WESTLAKE VILLAGE, Calif., Oct. 10, 2014 (GLOBE NEWSWIRE) — KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on September 26, 2014, the Compensation Committee of the Company’s Board of Directors granted two new employees options to purchase an aggregate of 12,500 shares of the Company…

Spinal Atrophy Drug From Isis Pharmaceuticals, Inc. Showing Promise, Says UBS

October 13, 2014 – 5:00 am | Edit Post

Cytori Therapeutics, Inc. Announces Closing Of Financing

October 13, 2014 – 5:00 am | Edit Post

SAN DIEGO–(BUSINESS WIRE)–Cytori Therapeutics, Inc. (NASDAQ: CYTX) announced today that it has completed the previously announced sale of shares of its Series A 3.6% convertible preferred stock pursuant to a registered direct offering representing gross proceeds of approximately $13.5 million. The preferred stock is convertible into shares of Cytoris common stock at the option of the investors at…

Scientists Create Mimic of ‘Good’ Cholesterol to Fight Heart Disease and Stroke

October 13, 2014 – 1:00 am | Edit Post

The molecule from the Ghadiri lab improved animal models’ cholesterol in just two weeks.

10 Tips for Scientists on Talking to the Media

October 13, 2014 – 1:00 am | Edit Post

Representatives from California Institute for Regenerative Medicine recently shared their insights into how to communicate research effectively during a media interview.

San Diego Researchers Receive $4.4 Million in New NIH ‘Big Data’ Initiative

October 13, 2014 – 12:00 am | Edit Post

“In fields such as genomics and proteomics, researchers require increasingly powerful tools to make sense of their findings,” says Andrew Su of TSRI and STSI who is a co-director of a new Center for Excellence for Big Data Computing.